The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 18, Issue 5 SPEC. ISS., 2004, Pages 755-771

  van der Spuy, Zephne M ^a   Dyer, Silke J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Anovulation; Apoptosis; Early pregnancy loss; Hyperandrogenaemia; Hyperinsulinaemia; Luteinizing hormone; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; BASIC FIBROBLAST GROWTH FACTOR; CLOMIFENE CITRATE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN; ESTRONE; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; INHIBIN B; INSULIN; INSULIN SENSITIZING AGENT; LUTEINIZING HORMONE; METFORMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; GROWTH PROMOTOR;

ANOVULATION; APOPTOSIS; ENDOMETRIAL DISEASE; FEMALE; FEMALE INFERTILITY; GONADOTROPIN RELEASE; GRANULOSA CELL; GYNECOLOGIC DISEASE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RELEASE; LUTEINIZING HORMONE RELEASE; OBESITY; OVARY DISEASE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PARACRINE SIGNALING; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; STEROIDOGENESIS; THECA CELL; OVARY FOLLICLE; PHYSIOLOGY; PREGNANCY;

ABORTION, SPONTANEOUS; FEMALE; GROWTH SUBSTANCES; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 15844421580     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2004.06.001     Document Type: Review

References (96)

1. D.W. Polson J. Adams J. Wadsworth & S. Franks Polycystic ovaries - a common finding in normal women Lancet 1 1988 870-872
2. E.S. Knochenhauer T.J. Key M. Kahsar-Miller et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study Journal of Clinical Endocrinology and Metabolism 83 1998 3078-3082
3. K.F. Michelmore A.H. Balen D.B. Dunger & M.P. Vessey Polycystic ovaries and associated clinical and biochemical features in young women Clinical Endocrinology (Oxford) 51 1999 779-786
4. G. Kovacs & C. Wood The current status of polycystic ovary syndrome Australian and New Zealand Journal of Obstetrics and Gynaecology 41 2001 65-68
5. T.L. Marx & A.E. Mehta Polycystic ovary syndrome: Pathogenesis and treatment over the short and long term Cleveland Clinical Journal of Medicine 70 2003 31-45
6. E. Kousta D.M. White E. Cela et al. The prevalence of polycystic ovaries in women with infertility Human Reproduction 14 1999 2720-2723
7. J. Adams S. Franks et al. D.W. Polson Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone Lancet 2 1985 1375-1379
8. P.E. Hughesdon Morphology and morphogenesis of the Stein-Leventhal Ovary and of the So-called "Hyperthecosis" Obstetrical and Gynecological Survey 37 2 1982 59-77
9. R. Homburg Involvement of growth factors in the pathophysiology of polycystic ovary syndrome Gynecological Endocrinology 12 1998 391-397
10. M. van der Meer P.G. Hompes et al. J.A. de Boer Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 83 1998 423-426
11. G.D. Hodgen The dominant ovarian follicle Fertility and Sterility 38 1982 0281-0300
12. S.G. Hillier P.F. Whitelaw & C.D. Smyth Follicular oestrogen synthesis: The "two-cell, two-gonadotrophin" model revisited Molecular and Cellular Endocrinology 100 1994 51-54
13. S.G. Hillier Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis Human Reproduction 9 1994 188-191
14. J. Yeh & E.Y. Adashi The ovarian life cycle In S.S.C. Yen R.B. Jaffe R.L. Barbieri (eds.) Reproductive Endocrinology 4th edn 1999 Saunders Philadelphia 153-190
15. E.L. Yong D.T. Baird R. Yates et al. Hormonal regulation of the growth and steroidogenic function of human granulosa cells Journal of Clinical Endocrinology and Metabolism 74 1992 842-849
16. S.S. Yen P. Vela & J. Rankin Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease Journal of Clinical Endocrinology and Metabolism 30 1970 435-442
17. B.C. Fauser & A.M. Van Heusden Manipulation of human ovarian function: Physiological concepts and clinical consequences Endocrine Review 18 1997 71-106
18. D.A. Magoffin A.J. Jakimiuk & A. Inhibin inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome Human Reproduction 13 1998 2693-2698
19. J.S. Laven B. Imani M.J. Eijkemans et al. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility Human Reproduction 16 2001 1359-1364
20. H. Mizunuma K. Andoh M. Obara et al. Serum immunoreactive inhibin levels in polycystic ovarian disease (PCOD) and hypogonadotropic amenorrhea Endocrine Journal 41 1994 409-414
21. G.M. Lockwood S. Muttukrishna N.P. Groome et al. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: A possible mechanism regulating emergence of the dominant follicle Journal of Clinical Endocrinology and Metabolism 83 1998 1730-1735
22. D. Willis H. Mason C. Gilling-Smith & S. Franks Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries Journal of Clinical Endocrinology and Metabolism 81 1996 302-309
23. D.S. Willis H. Watson H.D. Mason et al. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: Relevance to mechanism of anovulation Journal of Clinical Endocrinology and Metabolism 83 1998 3984-3991
24. R. Homburg The management of infertility associated with polycystic ovary syndrome Reproductive Biology and Endocrinology 1 2003 109-117
25. F.L. Teixeira Filho E.C. Baracat T.H. Lee et al. Journal of Clinical Endocrinology and Metabolism 87 2002 1337-1344
26. J. Dong D.F. Albertini K. Nishimori et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis Nature 383 1996 531-535
27. U.A. Vitt M. Hayashi C. Klein & A.J. Hsueh Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles Biology of Reproduction 62 2000 370-377
28. G. Almahbobi A. Nagodavithane & A.O. Trounson Effects of epidermal growth factor, transforming growth factor and androstenedione on follicular growth and aromatization in culture Human Reproduction 10 1995 2767-2772
29. T. Maruo J.B. Laoag-Fernandez & S. Takekida Regulation of granulosa cell proliferation and apoptosis during follicular development Gynecological Endocrinology 13 1999 410-419
30. H.D. Mason R. Margara R.M. Winston et al. Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries Clinical Endocrinology (Oxford) 33 1990 511-517
31. G. Almahbobi A. Misajon P. Hutchinson et al. Hyperexpression of epidermal growth factor receptors in granulosa cells from women with polycystic ovary syndrome Fertility and Sterility 70 1998 750-758
32. H.D. Mason L. Carr R. Leake & S. Franks Production of transforming growth factor- α by normal and polycystic ovaries Journal of Clinical Endocrinology and Metabolism 80 1995 2053-2056
33. K.S. Lee B.S. Joo Y.J. Na et al. Relationships between concentrations of tumor necrosis factor-α and nitric oxide in follicular fluid and oocyte quality Journal of Assisted Reproduction and Genetics 17 2000 222-228
34. G. Amato M. Conte G. Mazziotti et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles Obstetrics and Gynecology 101 2003 1177-1182
35. A. Amsterdam R. Sasson I. Keren-Tal et al. Alternative pathways of ovarian apoptosis: Death for life Biochemical Pharmacology 66 2003 1355-1362
36. T.E. Vaskivuo & J.S. Tapanainen Apoptosis in the human ovary Reproductive Biomedicine Online 6 2003 24-35
37. R. Homburg & A. Amsterdam Polysystic ovary syndrome - loss of the apoptotic mechanism in the ovarian follicles? Journal of Endocrinological Investigations 21 1998 552-557
38. S.Y. Hsu R.J. Lai M. Finegold & A.J. Hsueh Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis Endocrinology 137 1996 4837-4843
39. A. Dunaif J. Xia C.B. Book et al. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome Journal of Clinical Investigations 96 1995 801-810
40. J.S. Laven B. Imani M.J. Eijkemans & B.C. Fauser New approach to polycystic ovary syndrome and other forms of anovulatory infertility Obstetrical and Gynecological Survey 57 2002 755-767
41. R.B. Barnes The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies Journal of Endocrinological Investigations 21 1998 567-579
42. S. Franks D. White C. Gilling-Smith et al. Hypersecretion of androgens by polycystic ovaries: The role of genetic factors in the regulation of cytochrome P450c17 α Baillieres Clinical Endocrinology and Metabolism 10 1996 193-203
43. S. Franks H. Mason & D. Willis Follicular dynamics in the polycystic ovary syndrome Molecular and Cellular Endocrinology 163 2000 49-52
44. R.J. Norman M.J. Davies J. Lord & L.J. Moran The role of lifestyle modification in polycystic ovary syndrome Trends in Endocrinology and Metabolism 13 2002 251-257
45. J. Holte T. Bergh G. Gennarelli & L. Wide The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women Clinical Endocrinology (Oxford) 41 1994 473-481
46. B. Imani M.J. Eijkemans F.H. de Jong et al. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility Journal of Clinical Endocrinology and Metabolism 85 2000 676-682
47. P.G. Artini M. Monti F. Cristello et al. Vascular endothelial growth factor in females of reproductive age Gynecological Endocrinology 17 2003 477-492
48. L.B. Craig R.W. Ke & W.H. Kutteh Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss Fertility and Sterility 78 2002 487-490
49. C.J. Glueck P. Wang R.N. Fontaine et al. Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome Metabolism 48 1999 1589-1595
50. W.U. Atiomo J. Condon O. Adekanmi et al. Are women with polycystic ovary syndrome resistant to activated protein C? Fertility and Sterility 74 2000 1229-1232
51. W.U. Atiomo S.A. Bates J.E. Condon et al. The plasminogen activator system in women with polycystic ovary syndrome Fertility and Sterility 69 1998 236-241
52. D.K. Edmonds K.S. Lindsay J.F. Miller et al. Early embryonic mortality in women Fertility and Sterility 38 1982 447-453
53. G.M. Stirrat Recurrent miscarriage Lancet 336 1990 673-675
54. A.J. Wilcox C.R. Weinberg J.F. O'Connor et al. Incidence of early loss of pregnancy New England Journal of Medicine 319 1988 189-194
55. T.C. Li Recurrent miscarriage: Principles of management Human Reproduction 13 1998 478-482
56. D. Warburton & F.C. Fraser Spontaneous abortion risks in man: Data from reproductive histories collected in a medical genetics unit American Journal of Human Genetics 16 1964 1-25
57. H. Wramsby K. Fredga & P. Liedholm Chromosome analysis of human oocytes recovered from preovulatory follicles in stimulated cycles New England Journal of Medicine 316 1987 121-124
58. M. Sagle K. Bishop N. Ridley et al. Recurrent early miscarriage and polycystic ovaries British Medical Journal 297 1988 1027-1028
59. L. Regan E.J. Owen & H.S. Jacobs Hypersecretion of luteinising hormone, infertility, and miscarriage Lancet 336 1990 1141-1144
60. A.H. Balen S.L. Tan & H.S. Jacobs Hypersecretion of luteinising hormone: A significant cause of infertility and miscarriage British Journal of Obstetrics and Gynaecology 100 1993 1082-1089
61. R. Rebar H.L. Judd S.S. Yen et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome Journal of Clinical Investigations 57 1976 1320-1329
62. C.W. Burger T. Korsen H. van Kessel et al. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea Journal of Clinical Endocrinology and Metabolism 61 1985 1126-1132
63. A.P. Murdoch P.J. Diggle M.C. White et al. LH in polycystic ovary syndrome: Reproducibility and pulsatile secretion Journal of Endocrinology 121 1989 185-191
64. E.Y. Adashi A.J. Hsueh & S.S. Yen Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells Endocrinology 108 1981 1441-1449
65. R. Homburg N.A. Armar A. Eshel et al. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome British Medical Journal 297 1988 1024-1026
66. H. Watson D.S. Kiddy D. Hamilton-Fairley et al. Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage Human Reproduction 8 1993 829-833
67. H.S. Jacobs & R.R. Homburg The endocrinology of conception Baillieres Clinical Endocrinology and Metabolism 4 1990 195-205
68. Z. Shoham R. Borenstein B. Lunenfeld & C. Pariente Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles Clinical Endocrinology (Oxford) 33 1990 271-278
69. D.M. Saunders P.A. Lancaster & E.L. Pedisich Increased pregnancy failure rates after clomiphene following assisted reproductive technology Human Reproduction 7 1992 1154-1158
70. R. Homburg T. Levy D. Berkovitz et al. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome Fertility and Sterility 59 1993 527-531
71. A.H. Balen S.L. Tan J. MacDougall & H.S. Jacobs Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin Human Reproduction 8 1993 959-964
72. K. Clifford R. Rai H. Watson et al. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial British Medical Journal 312 1996 1508-1511
73. R. Rai M. Backos F. Rushworth & L. Regan Polycystic ovaries and recurrent miscarriage-a reappraisal Human Reproduction 15 2000 612-615
74. G.S. Conway J.W. Honour & H.S. Jacobs Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients Clinical Endocrinology (Oxford) 30 1989 459-470
75. A.H. Balen G.S. Conway G. Kaltsas et al. Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients Human Reproduction 10 1995 2107-2111
76. S. Aksoy H. Celikkanat S. Senoz & O. Gokmen The prognostic value of serum estradiol, progesterone, testosterone and free testosterone levels in detecting early abortions European Journal of Obstetrics, Gynecology and Reproductive Biology 67 1996 5-8
77. M. Tulppala U.H. Stenman B. Cacciatore & O. Ylikorkala Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: Prospective study in 50 women British Journal of Obstetrics and Gynaecology 100 1993 348-352
78. M.A. Okon S.M. Laird E.M. Tuckerman & T.C. Li Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function Fertility and Sterility 69 1998 682-690
79. E.M. Tuckerman M.A. Okon T. Li & S.M. Laird Do androgens have a direct effect on endometrial function? An in vitro study Fertility and Sterility 74 2000 771-779
80. M.M. Huber-Buchholz D.G. Carey & R.J. Norman Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: Role of insulin sensitivity and luteinizing hormone Journal of Clinical Endocrinology and Metabolism 84 1999 1470-1474
81. J.X. Wang M.J. Davies & R.J. Norman Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment Human Reproduction 16 2001 2606-2609
82. E.M. Velazquez S. Mendoza T. Hamer et al. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, hyperandrogenaemia, and systolic blood pressure, while facilitating normal menses and pregnancy Metabolism 43 1994 647-654
83. D.J. Jakubowicz M.J. Iuorno S. Jakubowicz et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 87 2002 524-529
84. C.J. Glueck H. Phillips D. Cameron et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study Fertility and Sterility. 75 2001 46-52
85. D. Hamilton-Fairley D. Kiddy H. Watson et al. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin British Journal of Obstetrics and Gynaecology 99 1992 128-131
86. P. Fedorcsak R. Storeng P.O. Dale et al. Obesity is a risk factor for early pregnancy loss after IVF or ICSI Acta Obstetrica et Gynecologica Scandinavica 79 2000 43-48
87. M.F. Costello & J.A. Eden A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome Fertility and Sterility 79 2003 1-13
88. A.M. Clark B. Thornley L. Tomlinson et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment Human Reproduction 13 1998 1502-1505
89. J.C. Gris S. Neveu P. Mares et al. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology Journal of Laboratory and Clinical Medicine 122 1993 606-615
90. J.C. Gris S. Ripart-Neveu C. Maugard et al. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study Thrombosis and Haemostasis 77 1997 1096-1103
91. E. Diamanti-Kandarakis G. Spina C. Kouli & I. Migdalis Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy Journal of Clinical Endocrinology and Metabolism 86 2001 4666-4673
92. G. Paradisi H.O. Steinberg A. Hempfling et al. Polycystic ovary syndrome is associated with endothelial dysfunction Circulation 103 2001 1410-1415
93. E. Reshef Z.M. Lei C.V. Rao et al. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua Journal of Clinical Endocrinology and Metabolism 70 1990 421-430
94. K. Horie K. Takakura H. Fujiwara et al. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression Human Reproduction 7 1992 184-190
95. H. Watson S. Franks & R.C. Bonney Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture Human Reproduction 13 1998 2585-2591
96. D. Cermik B. Selam & H.S. Taylor Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 88 2003 238-243